Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Syringe Detects Loss of Resistance

By HospiMedica staff writers
Posted on 05 Mar 2007
A new syringe automatically detects loss of resistance (LOR) during epidural anesthesia, the administering of medications directly into the epidural space.

The Episure AutoDetect syringe is a spring-loaded, automatic LOR syringe used in epidural anesthesia. More...
The syringe utilizes a specially engineered internal compression spring that applies precise and constant force on the plunger that automatically depresses when the epidural needle enters the epidural space, eliminating the subjective feel required by the anesthetist with standard LOR syringes. In addition to providing a visual confirmation, the Episure allows the practitioner to continuously advance the epidural needle with both hands, resulting in superior control and sensitivity.

"The Episure allows performing the constant pressure technique while maintaining excellent control of the epidural needle. I believe that you could demonstrate that one could perform the procedure quicker and you might have a lower incidence of inadvertent dural punctures, and it is a safer technique,” said Ashraf Habib, M.D., an assistant professor at Duke University Medical Center (Durham, NC, USA). "I believe that practitioners with different levels of experience can benefit from using the Episure syringes.”

The Episure AutoDetect syringe is a product of Indigo Orb (Irvine, CA, USA), and has been approved by both the U.S. Food and Drug Administration (FDA) and the European Community (EC mark).

Traditionally, epidural anesthesia is performed using a standard LOR syringe that requires the practitioner to rely on thumb pressure to feel for change in resistance while advancing the needle into the epidural space. However, inadvertent dural punctures with this technique could cause severe headaches and call for bed rest, if the epidural needle is incorrectly placed.


Related Links:
Indigo Orb
Duke University Medical Center

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.